These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 16503991)
1. Type-2 diabetes-induced changes in vascular extracellular matrix gene expression: relation to vessel size. Song W; Ergul A Cardiovasc Diabetol; 2006 Feb; 5():3. PubMed ID: 16503991 [TBL] [Abstract][Full Text] [Related]
2. Evidence for vasculoprotective effects of ETB receptors in resistance artery remodeling in diabetes. Sachidanandam K; Portik-Dobos V; Harris AK; Hutchinson JR; Muller E; Johnson MH; Ergul A Diabetes; 2007 Nov; 56(11):2753-8. PubMed ID: 17670915 [TBL] [Abstract][Full Text] [Related]
3. Type 2 diabetes causes remodeling of cerebrovasculature via differential regulation of matrix metalloproteinases and collagen synthesis: role of endothelin-1. Harris AK; Hutchinson JR; Sachidanandam K; Johnson MH; Dorrance AM; Stepp DW; Fagan SC; Ergul A Diabetes; 2005 Sep; 54(9):2638-44. PubMed ID: 16123352 [TBL] [Abstract][Full Text] [Related]
4. Microvascular versus macrovascular dysfunction in type 2 diabetes: differences in contractile responses to endothelin-1. Sachidanandam K; Harris A; Hutchinson J; Ergul A Exp Biol Med (Maywood); 2006 Jun; 231(6):1016-21. PubMed ID: 16741041 [TBL] [Abstract][Full Text] [Related]
5. Differential effects of diet-induced dyslipidemia and hyperglycemia on mesenteric resistance artery structure and function in type 2 diabetes. Sachidanandam K; Hutchinson JR; Elgebaly MM; Mezzetti EM; Wang MH; Ergul A J Pharmacol Exp Ther; 2009 Jan; 328(1):123-30. PubMed ID: 18941121 [TBL] [Abstract][Full Text] [Related]
6. Glycemic control prevents microvascular remodeling and increased tone in type 2 diabetes: link to endothelin-1. Sachidanandam K; Hutchinson JR; Elgebaly MM; Mezzetti EM; Dorrance AM; Motamed K; Ergul A Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R952-9. PubMed ID: 19176890 [TBL] [Abstract][Full Text] [Related]
10. Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes. Portik-Dobos V; Harris AK; Song W; Hutchinson J; Johnson MH; Imig JD; Pollock DM; Ergul A Am J Physiol Regul Integr Comp Physiol; 2006 Feb; 290(2):R435-41. PubMed ID: 16239374 [TBL] [Abstract][Full Text] [Related]
11. Stress upregulates arterial matrix metalloproteinase expression and activity via endothelin A receptor activation. Ergul A; Portik-Dobos V; Giulumian AD; Molero MM; Fuchs LC Am J Physiol Heart Circ Physiol; 2003 Nov; 285(5):H2225-32. PubMed ID: 12842810 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of ET(A) and ET(B) receptor antagonism on oxidative stress in type 2 diabetes. Elgebaly MM; Portik-Dobos V; Sachidanandam K; Rychly D; Malcom D; Johnson MH; Ergul A Vascul Pharmacol; 2007; 47(2-3):125-30. PubMed ID: 17597010 [TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis. Merdad A; Karim S; Schulten HJ; Dallol A; Buhmeida A; Al-Thubaity F; Gari MA; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH Anticancer Res; 2014 Mar; 34(3):1355-66. PubMed ID: 24596383 [TBL] [Abstract][Full Text] [Related]
14. Endothelial endothelin B receptor-mediated prevention of cerebrovascular remodeling is attenuated in diabetes because of up-regulation of smooth muscle endothelin receptors. Kelly-Cobbs AI; Harris AK; Elgebaly MM; Li W; Sachidanandam K; Portik-Dobos V; Johnson M; Ergul A J Pharmacol Exp Ther; 2011 Apr; 337(1):9-15. PubMed ID: 21205912 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms underlying enhanced vasorelaxant response to protease-activated receptor 2-activating peptide in type 2 diabetic Goto-Kakizaki rat mesenteric artery. Matsumoto T; Ishida K; Taguchi K; Kobayashi T; Kamata K Peptides; 2009 Sep; 30(9):1729-34. PubMed ID: 19540892 [TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase enhances big-endothelin-1 constriction in mesenteric vessels of pregnant rats with reduced uterine blood flow. Abdalvand A; Morton JS; Bourque SL; Quon AL; Davidge ST Hypertension; 2013 Feb; 61(2):488-93. PubMed ID: 23297376 [TBL] [Abstract][Full Text] [Related]
17. Involvement of MMPs in the outward remodeling of collateral mesenteric arteries. Haas TL; Doyle JL; Distasi MR; Norton LE; Sheridan KM; Unthank JL Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2429-37. PubMed ID: 17644578 [TBL] [Abstract][Full Text] [Related]
18. Early inhibition of EGFR signaling prevents diabetes-induced up-regulation of multiple gene pathways in the mesenteric vasculature. Benter IF; Benboubetra M; Hollins AJ; Yousif MH; Canatan H; Akhtar S Vascul Pharmacol; 2009 Oct; 51(4):236-45. PubMed ID: 19577003 [TBL] [Abstract][Full Text] [Related]
19. Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling. Pu Q; Neves MF; Virdis A; Touyz RM; Schiffrin EL Hypertension; 2003 Jul; 42(1):49-55. PubMed ID: 12782645 [TBL] [Abstract][Full Text] [Related]
20. 3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases. Xie Z; Yuan H; Yin Y; Zeng X; Bai R; Glazer RI BMC Cancer; 2006 Mar; 6():77. PubMed ID: 16551362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]